Where the Money Goes

You are here

Northwestern Mutual Foundation

The mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $35 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination.

Co-Funded Projects

Project Title Institutions Co-Funder(s)
The Role of Neuropeptide Y and Its Y5 Receptor in Dissemination of Refractory Neuroblastoma Georgetown University Northwestern Mutual Foundation
Targeting SHP2 in Receptor Tyrosine Kinase-driven Neuroblastomas University of Pennsylvania Northwestern Mutual Foundation
Characterizing PPM1D Mutations as Oncogenic Drivers of Diffuse Intrinsic Pontine Glioma Brown University Northwestern Mutual Foundation
Phenotype of Tumor-Associated Antigen Presenting Cells after Blocking Indoleamine 2-3-Dioxygenase Augusta University Northwestern Mutual Foundation
Investigating the Interplay between Nucleophosmin and Caspase-2 in Determining Chemosensitivity in Childhood AML - Kenneth McSherry (2018) University College Dublin Northwestern Mutual Foundation
Targeted Inhibition of CREB for the Treatment of Pediatric Acute Myeloid Leukemia Oakland University Northwestern Mutual Foundation
PDL-1 Expression on Tumor Cells Mediates C8 Cytotoxic T Cell (CTL) Resistance Ohio State University Northwestern Mutual Foundation
Be a Dog’s Best Friend, Help a Child Oregon State University Northwestern Mutual Foundation
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition St. Jude Children’s Research Hospital Northwestern Mutual Foundation
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy Fred Hutchinson Cancer Research Center Northwestern Mutual Foundation

Pages